Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Hemispherx Biopharma Inc (NYSE MKT LLC:HEB)

0.1776
Delayed Data
As of 1:23pm ET
 -0.0012 / -0.67%
Today’s Change
0.14
Today|||52-Week Range
0.40
-28.96%
Year-to-Date
No recent news for Hemispherx Biopharma Inc.

Today’s Trading

Previous close0.18
Today’s open0.18
Day’s range0.18 - 0.18
Volume306,180
Average volume (3 months)691,702
Market cap$44.1M
Dividend yield--
Data as of 1:23pm ET, 09/02/2015

Growth & Valuation

Earnings growth (last year)+10.00%
Earnings growth (this year)--
Earnings growth (next 5 years)+35.00%
Revenue growth (last year)+31.33%
P/E ratioNM
Price/Sales238.95
Price/Book1.46

Competitors

 Today’s
change
Today’s
% change
PRANPrana Biotechnology ...-0.01-1.12%
BIODBiodel Inc-0.02-2.78%
CASICASI Pharmaceuticals...-0.05-3.36%
ENZNEnzon Pharmaceutical...+0.02+2.16%
Data as of 1:28pm ET, 09/02/2015

Financials

Last reporting date--
EPS forecast (this quarter)--
Annual revenue (last year)$197.0K
Annual profit (last year)-$17.5M
Net profit margin-8,857.87%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, CEO &
Chief Science Officer
William A. Carter
Senior Vice President-
Operations
Wayne S. Springate
Corporate headquarters
Philadelphia, Pennsylvania

Forecasts

Partner Offers